Investing
Published September 30, 2026
Jefferies Highlights Three Biotech Stocks With Blockbuster Potential - Investing.com
Read the full story at Investing
The company's single-dose oral psychedelic DT120 has produced three positive Phase III datasets in major depressive disorder and generalized.
Surfaced by this Google Alert
- Psychedelic biotech